Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Juergen Luhm; Ulrich Langenkamp; Jenny Hensel; Christoph Frohn; Joerg M Brand; Holger Hennig; Lothar Rink; Petra Koritke; Nadine Wittkopf; David L Williams

doi:10.1186/1471-2172-7-5

Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Identifier:nobleid.org/w1/20260515/CE2C4449

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE2C4449.svg?ark=w1%2F20260515%2FCE2C4449)](https://nobleid.org/work/w1/20260515/CE2C4449)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Identifier:nobleid.org/w1/20260515/CE2C4449

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE2C4449.svg?ark=w1%2F20260515%2FCE2C4449)](https://nobleid.org/work/w1/20260515/CE2C4449)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work